C 0001952985 XXXXXXXX LIVE false true false Novatek Pharmaceuticals, Inc. Corporation DE 04-30-2020 3569 Business Center Drive Suite 110 Pearland TX 77584 www.novatekpharmceuticals.com N Deal Maker 0001872856 008-70756 315324 3.0% of the amount raised in the Offering A cash expense of $16,500 for set-up fees and $2,000 per month maintenance fees payable to DealMaker Securities, as well as 1% of the total Securities sold in the offering Common Stock 25000 2.00000 50000.00 Y Other Other: at the Company's discretion 5000000.00 12-14-2023 5 16640.00 78288.00 16640.00 78288.00 0.00 0.00 2207386.00 1076299.00 2253479.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3446214.00 1148011.00 AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY B5 1V Novatek Pharmaceuticals, Inc. Mohamed Kaseb CEO Alex Saliba CFO 12-21-2022